Dr. Reddy’s to Release Q4 and Full Year FY16 Results on May 12, 2016; Earnings Call Slated for May 12, 6.30 PM IST / 9.00 AM EDT

HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories (NYSE: RDY; NSE: DRREDDY; BSE: 500124) will
announce results for the Fourth Quarter and Full Year ended March 31,
2016 on Thursday, May 12, 2016 after the Board Meeting. The results will
be available on the Company’s website www.drreddys.com.

Earnings Call

Following the release, the management of the Company will host an
Earnings Call to discuss the Company’s financial performance. (Dial
In and other details given below)

Audio Webcast

The audio webcast of the earnings call will be available to all
interested parties at www.drreddys.com.
Please visit the web site at least fifteen minutes ahead of the
scheduled start time to register and to download and install any
necessary audio software. Participants in the webcast can listen to the
proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through May 16, 2016. For
play back dial in phone No: 022 3065 2322, 022 61813322 and ID: 375#.

Transcript

The transcript of the Earnings Call will also be available on the
Company’s website

No password/pin number is necessary to dial in to any of the other
calls. As participation in the call is limited, early registration is
encouraged. The operator will provide instructions on asking questions
before and during the call.

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (NYSE: RDY; NSE:
DRREDDY; BSE: 500124) is an integrated pharmaceutical company, committed
to accelerating access to providing affordable and innovative medicines
for healthier lives. Through its three businesses – Pharmaceutical
Services & Active Ingredients, Global Generics and Proprietary Products
– Dr. Reddy’s offers a portfolio of products and services including
APIs, custom pharmaceutical services, generics, biosimilars and
differentiated formulations. Our major therapeutic areas of focus are
gastro-intestinal, cardiovascular, diabetology, oncology, pain
management and anti-infectives. Dr. Reddy’s operates in markets across
the globe. Our major markets include – USA, Russia & CIS, Venezuela and
India. For more information, log on to: www.drreddys.com.

Disclaimer: This press release may include statements of future
expectations and other forward-looking statements that are based on the
management’s current views and assumptions and involve known or unknown
risks and uncertainties that could cause actual results, performance or
events to differ materially from those expressed or implied in such
statements. In addition to statements which are forward-looking by
reason of context, the words « may, » « will, » « should, » « expects, »
« plans, » « intends, » « anticipates, » « believes, » « estimates, » « predicts, »
« potential, » or « continue » and similar expressions identify
forward-looking statements. Actual results, performance or events may
differ materially from those in such statements due to without
limitation, (i) general economic conditions such as performance of
financial markets, credit defaults, currency exchange rates, interest
rates, persistency levels and frequency / severity of insured loss
events, (ii) mortality and morbidity levels and trends, (iii) changing
levels of competition and general competitive factors, (iv) changes in
laws and regulations and in the policies of central banks and/or
governments, (v) the impact of acquisitions or reorganisation, including
related integration issues.

The company assumes no obligation to update any information contained
herein.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160426005974/en/